DYAI: Dyadic International Inc. Stocks News on November 17, 2025

DYAI

Zacks Small Cap Research

3 days ago

DYAI: Purchase Orders Rolling In

DYAI

Motley Fool

4 days ago

Dyadic (DYAI) Q3 2025 Earnings Call Transcript

DYAI

GuruFocus.com

5 days ago

Dyadic International Inc (DYAI) Q3 2025 Earnings Call Highlights: Transition to Commercial ...

Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress

DYAI

GlobeNewswire

5 days ago

Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress

How Analyst Views on Dyadic International Are Shifting With New Commercialization and Partnership Risks

DYAI

Simply Wall St.

10 days ago

How Analyst Views on Dyadic International Are Shifting With New Commercialization and Partnership Risks

Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025

DYAI

GlobeNewswire

19 days ago

Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025

Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications

DYAI

GlobeNewswire

5 months ago

Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications

Dyadic International First Quarter 2025 Earnings: US$0.068 loss per share (vs US$0.07 loss in 1Q 2024)

DYAI

Simply Wall St.

6 months ago

Dyadic International First Quarter 2025 Earnings: US$0.068 loss per share (vs US$0.07 loss in 1Q 2024)

DYAI

Zacks Small Cap Research

6 months ago

DYAI: Fermbox Purchase Order

Dyadic Reports First Quarter 2025 Financial Results and Highlights of Recent Company Progress

DYAI

GlobeNewswire

6 months ago

Dyadic Reports First Quarter 2025 Financial Results and Highlights of Recent Company Progress

Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025

DYAI

GlobeNewswire

7 months ago

Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025

Dyadic to Present at World Vaccine Congress | Washington

DYAI

GlobeNewswire

7 months ago

Dyadic to Present at World Vaccine Congress | Washington

Dyadic International Full Year 2024 Earnings: Misses Expectations

DYAI

Simply Wall St.

8 months ago

Dyadic International Full Year 2024 Earnings: Misses Expectations

DYAI

Zacks Small Cap Research

8 months ago

DYAI: CEPI Grants Recognize C1

DYAI

Thomson Reuters StreetEvents

8 months ago

Q4 2024 Dyadic International Inc Earnings Call

DYAI

GuruFocus.com

8 months ago

Dyadic International Inc (DYAI) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ...

Dyadic Reports 2024 Year-End Financial Results and Business Updates

DYAI

GlobeNewswire

8 months ago

Dyadic Reports 2024 Year-End Financial Results and Business Updates

DYAI

GuruFocus.com

8 months ago

What To Expect From Dyadic International Inc (DYAI) Q4 2024 Earnings

Dyadic Announces Funding Award from CEPI to Use C1 to Accelerate Development of Protein-Based Vaccines

DYAI

GlobeNewswire

8 months ago

Dyadic Announces Funding Award from CEPI to Use C1 to Accelerate Development of Protein-Based Vaccines

Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025

DYAI

GlobeNewswire

8 months ago

Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025

Dyadic to Attend Multiple Industry Events in March

DYAI

GlobeNewswire

8 months ago

Dyadic to Attend Multiple Industry Events in March

3 US Penny Stocks With Market Caps Over $40M To Consider

DYAI

Simply Wall St.

9 months ago

3 US Penny Stocks With Market Caps Over $40M To Consider

DYAI

Zacks Small Cap Research

9 months ago

DYAI: Looking Toward Product Revenues

Dyadic Provides Business Update; Dyadic to Attend the 43rd Annual J.P. Morgan Healthcare Conference

DYAI

GlobeNewswire

10 months ago

Dyadic Provides Business Update; Dyadic to Attend the 43rd Annual J.P. Morgan Healthcare Conference

Dyadic International And 2 Other US Penny Stocks To Watch

DYAI

Simply Wall St.

a year ago

Dyadic International And 2 Other US Penny Stocks To Watch

Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology

DYAI

GlobeNewswire

a year ago

Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology

Top US Penny Stocks To Watch In November 2024

DYAI

Simply Wall St.

a year ago

Top US Penny Stocks To Watch In November 2024

Dyadic International Third Quarter 2024 Earnings: Beats Expectations

DYAI

Simply Wall St.

a year ago

Dyadic International Third Quarter 2024 Earnings: Beats Expectations

DYAI

Zacks Small Cap Research

a year ago

DYAI: Milestones Achieved; Product Revenues Next?

DYAI

GuruFocus.com

a year ago

Dyadic International Inc (DYAI) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ...

Dyadic Announces Third Quarter 2024 Financial Results and Strategic Progress Across Key Markets

DYAI

GlobeNewswire

a year ago

Dyadic Announces Third Quarter 2024 Financial Results and Strategic Progress Across Key Markets

DYAI

GuruFocus.com

a year ago

Earnings To Watch: Dyadic International Inc (DYAI) Reports Q3 2024 Result

Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

DYAI

GlobeNewswire

a year ago

Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

DYAI

GuruFocus.com

a year ago

Dyadic International Inc (DYAI) Q2 2024 Earnings Call Highlights: Strategic Positioning Amid ...

Dyadic Expands Global Presence with Participation in Key Industry Events

DYAI

GlobeNewswire

a year ago

Dyadic Expands Global Presence with Participation in Key Industry Events

Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference

DYAI

GlobeNewswire

a year ago

Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference

DYAI

Zacks Small Cap Research

a year ago

DYAI: Product Revenues Next Year

Dyadic Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress

DYAI

GlobeNewswire

a year ago

Dyadic Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress

Dyadic to Report Second Quarter 2024 Financial Results on Tuesday, August 13, 2024

DYAI

GlobeNewswire

a year ago

Dyadic to Report Second Quarter 2024 Financial Results on Tuesday, August 13, 2024

DYAI

Zacks Small Cap Research

a year ago

DYAI: Moo-ve Over Bovines, C1's Taking On Albumin

Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership

DYAI

GlobeNewswire

a year ago

Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership

Dyadic to Attend Industry Events in June

DYAI

GlobeNewswire

a year ago

Dyadic to Attend Industry Events in June

DYAI

GuruFocus.com

2 years ago

Dyadic International Inc (DYAI) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review ...

DYAI

Zacks Small Cap Research

2 years ago

DYAI: Product Revenues Next Year

Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress

DYAI

GlobeNewswire

2 years ago

Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress

Dyadic to Attend Industry and Investor Events in May

DYAI

GlobeNewswire

2 years ago

Dyadic to Attend Industry and Investor Events in May

Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024

DYAI

GlobeNewswire

2 years ago

Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024

DYAI

Insider Monkey

2 years ago

Dyadic International, Inc. (NASDAQ:DYAI) Q4 2023 Earnings Call Transcript

DYAI

Zacks Small Cap Research

2 years ago

DYAI: Capital Raise to Accelerate Near Term Revenue Growth

DYAI

Thomson Reuters StreetEvents

2 years ago

Q4 2023 Dyadic International Inc Earnings Call

Dyadic Reports 2023 Full Year Results and Recent Company Progress

DYAI

GlobeNewswire

2 years ago

Dyadic Reports 2023 Full Year Results and Recent Company Progress

Dyadic Announces Change in Board and Management Leadership Roles

DYAI

GlobeNewswire

2 years ago

Dyadic Announces Change in Board and Management Leadership Roles

Dyadic to Attend Industry Events in April

DYAI

GlobeNewswire

2 years ago

Dyadic to Attend Industry Events in April

Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications

DYAI

GlobeNewswire

2 years ago

Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications

Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California

DYAI

GlobeNewswire

2 years ago

Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California

Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024

DYAI

GlobeNewswire

2 years ago

Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024

CORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization

DYAI

GlobeNewswire

2 years ago

CORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization

Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization

DYAI

GlobeNewswire

2 years ago

Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization

Dyadic to Attend Industry Events in March

DYAI

GlobeNewswire

2 years ago

Dyadic to Attend Industry Events in March

Dyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production Platform

DYAI

GlobeNewswire

2 years ago

Dyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production Platform

Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions

DYAI

GlobeNewswire

2 years ago

Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions

DYAI

GlobeNewswire

2 years ago

Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions

DYAI

Zacks Small Cap Research

2 years ago

DYAI: Catching Up With Dyadic

Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing

DYAI

GlobeNewswire

2 years ago

Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing

Dyadic Announces Research and Development Collaboration Agreement with Global Biopharmaceutical Company

DYAI

GlobeNewswire

2 years ago

Dyadic Announces Research and Development Collaboration Agreement with Global Biopharmaceutical Company

Dyadic to Attend BIO CEO & Investor Conference and European Industry Events

DYAI

GlobeNewswire

2 years ago

Dyadic to Attend BIO CEO & Investor Conference and European Industry Events

FS Bancorp (NASDAQ:FSBW) Is Increasing Its Dividend To $0.26

DYAI

Simply Wall St.

2 years ago

FS Bancorp (NASDAQ:FSBW) Is Increasing Its Dividend To $0.26

First US Bancshares Full Year 2023 Earnings: EPS: US$1.42 (vs US$1.13 in FY 2022)

DYAI

Simply Wall St.

2 years ago

First US Bancshares Full Year 2023 Earnings: EPS: US$1.42 (vs US$1.13 in FY 2022)

DYAI

Associated Press Finance

2 years ago

Peoples Financial Services: Q4 Earnings Snapshot

United Security Bancshares (UBFO) Reports Record Net Income for 2023

DYAI

GuruFocus.com

2 years ago

United Security Bancshares (UBFO) Reports Record Net Income for 2023

PEOPLES FINANCIAL SERVICES CORP. Reports Unaudited Fourth Quarter and Year to Date 2023 Earnings

DYAI

PR Newswire

2 years ago

PEOPLES FINANCIAL SERVICES CORP. Reports Unaudited Fourth Quarter and Year to Date 2023 Earnings

Eton Pharmaceuticals (NASDAQ:ETON) investors are sitting on a loss of 50% if they invested three years ago

DYAI

Simply Wall St.

2 years ago

Eton Pharmaceuticals (NASDAQ:ETON) investors are sitting on a loss of 50% if they invested three years ago

DYAI

Newsfile

2 years ago

Dyadic International, Inc Invites You to Join Us at The Microcap Conference

Landmark Bancorp, Inc. Announces Conference Call to Discuss Fourth Quarter 2023 Earnings

DYAI

GlobeNewswire

2 years ago

Landmark Bancorp, Inc. Announces Conference Call to Discuss Fourth Quarter 2023 Earnings

DZS Extends Partnership with Andorix to Transform the Infrastructure and Commercial Management Economics of Historical Landmarks

DYAI

GlobeNewswire

2 years ago

DZS Extends Partnership with Andorix to Transform the Infrastructure and Commercial Management Economics of Historical Landmarks

Specialty Retail Stocks Q3 Highlights: Academy Sports (NASDAQ:ASO)

DYAI

StockStory

2 years ago

Specialty Retail Stocks Q3 Highlights: Academy Sports (NASDAQ:ASO)

Institutional investors may adopt severe steps after Magnachip Semiconductor Corporation's (NYSE:MX) latest 10% drop adds to a year losses

DYAI

Simply Wall St.

2 years ago

Institutional investors may adopt severe steps after Magnachip Semiconductor Corporation's (NYSE:MX) latest 10% drop adds to a year losses

Tiziana Life Sciences Announces Updated Clinical and PET Scan Findings for Intranasal Foralumab in Two New Multiple Sclerosis Patients

DYAI

GlobeNewswire

2 years ago

Tiziana Life Sciences Announces Updated Clinical and PET Scan Findings for Intranasal Foralumab in Two New Multiple Sclerosis Patients

DYAI

Market Exclusive

2 years ago

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Eltek (NASDAQ:ELTK) Is Very Good At Capital Allocation

DYAI

Simply Wall St.

2 years ago

Eltek (NASDAQ:ELTK) Is Very Good At Capital Allocation

Urban Farming Frontiers: 3 Stocks Growing Greens in the City

DYAI

InvestorPlace

2 years ago

Urban Farming Frontiers: 3 Stocks Growing Greens in the City

IN8bio Highlights Recent Company Accomplishments and Outlines 2024 Pipeline Goals

DYAI

GlobeNewswire

2 years ago

IN8bio Highlights Recent Company Accomplishments and Outlines 2024 Pipeline Goals

We Like Ituran Location and Control's (NASDAQ:ITRN) Returns And Here's How They're Trending

DYAI

Simply Wall St.

2 years ago

We Like Ituran Location and Control's (NASDAQ:ITRN) Returns And Here's How They're Trending

Dyadic to Attend J.P. Morgan 42nd Annual Healthcare Conference

DYAI

GlobeNewswire

2 years ago

Dyadic to Attend J.P. Morgan 42nd Annual Healthcare Conference

BrainsWay Highlights Expanded Deep TMS™ Access with Growing Western U.S. Network

DYAI

GlobeNewswire

2 years ago

BrainsWay Highlights Expanded Deep TMS™ Access with Growing Western U.S. Network

Not Many Are Piling Into P3 Health Partners Inc. (NASDAQ:PIII) Just Yet

DYAI

Simply Wall St.

2 years ago

Not Many Are Piling Into P3 Health Partners Inc. (NASDAQ:PIII) Just Yet

Accuray Initiates Sales of the VitalHold™ Solution in Japan, Supporting Surface-guided Radiation Therapy on the Radixact® System

DYAI

PR Newswire

2 years ago

Accuray Initiates Sales of the VitalHold™ Solution in Japan, Supporting Surface-guided Radiation Therapy on the Radixact® System

Epsilon Energy Ltd.'s (NASDAQ:EPSN) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

DYAI

Simply Wall St.

2 years ago

Epsilon Energy Ltd.'s (NASDAQ:EPSN) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Dyadic Attends Investor Events in December

DYAI

GlobeNewswire

2 years ago

Dyadic Attends Investor Events in December

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award

DYAI

GlobeNewswire

2 years ago

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award

Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate

DYAI

GlobeNewswire

2 years ago

Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate

Perma-Fix Joint Venture Receives Notice of Intent to Award European Waste Treatment Contract Valued at up to EUR 50 Million

DYAI

GlobeNewswire

2 years ago

Perma-Fix Joint Venture Receives Notice of Intent to Award European Waste Treatment Contract Valued at up to EUR 50 Million

DYAI

Simply Wall St.

2 years ago

Shareholders in Dyadic International (NASDAQ:DYAI) are in the red if they invested three years ago

Dyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in Africa

DYAI

GlobeNewswire

2 years ago

Dyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in Africa

Low-Priced Office REITs Are On Fire This Week

DYAI

Benzinga

2 years ago

Low-Priced Office REITs Are On Fire This Week

Down -84.82% in 4 Weeks, Here's Why You Should You Buy the Dip in Aclaris (ACRS)

DYAI

Zacks

2 years ago

Down -84.82% in 4 Weeks, Here's Why You Should You Buy the Dip in Aclaris (ACRS)

VIZSLA SILVER IS HONORED TO WELCOME MINING HALL OF FAME MEMBER EDUARDO LUNA TO ITS BOARD OF DIRECTORS

DYAI

CNW Group

2 years ago

VIZSLA SILVER IS HONORED TO WELCOME MINING HALL OF FAME MEMBER EDUARDO LUNA TO ITS BOARD OF DIRECTORS

Werewolf Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

DYAI

GlobeNewswire

2 years ago

Werewolf Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

Allot to Release Third Quarter 2023 Earnings on November 16, 2023 and Reschedules Conference Call to November 22, 2023

DYAI

GlobeNewswire

2 years ago

Allot to Release Third Quarter 2023 Earnings on November 16, 2023 and Reschedules Conference Call to November 22, 2023

Farallon Capital: A Global and Diversified Hedge Fund and its Top Stock Picks

DYAI

Insider Monkey

2 years ago

Latest Dyadic International Inc. (DYAI) News on November 17, 2025

Share on Social Networks: